Skip to main navigation Skip to search Skip to main content

Catholic University of Korea Reports Findings in Biomarkers (Clinical Value of the Systemic Immune Inflammation Index and PD-L1 Expression in Advanced NSCLC Treated with Pembrolizumab: Real-World Preliminary Study)

Press/Media

Period17 Jun 2026

Media coverage

1

Media coverage

  • TitleCatholic University of Korea Reports Findings in Biomarkers (Clinical Value of the Systemic Immune Inflammation Index and PD-L1 Expression in Advanced NSCLC Treated with Pembrolizumab: Real-World Preliminary Study)
    Media name/outletImmunotherapy Daily
    Country/TerritoryUnited States
    Date17/06/26
    PersonsSeok-Geun Lee